Swedish Orphan Biovitrum ... (BIOVF)

PNK: BIOVF · Real-Time Price · USD

30.66

0.00 (0.00%)

At close: Apr 30, 2025, 10:30 AM

Swedish Orphan Biovitrum AB (publ) Income Statement

Financials in SEK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	26.03B	22.12B	18.79B	15.53B	15.26B	14.25B	9.14B	6.51B	5.2B
Cost of Revenue	5.79B	5B	4.78B	3.48B	3.23B	3.33B	2.42B	1.85B	1.55B
Gross Profit	20.24B	17.13B	14.01B	12.04B	12.04B	10.91B	6.72B	4.66B	3.65B
Operating Income	5.63B	4.07B	3.81B	3.73B	4.82B	4.53B	3.12B	1.6B	1.13B
Interest Income	n/a	27M	5M	419M	1M	5M	2.74M	1.22M	1.43M
Pretax Income	4.41B	2.95B	3.32B	3.29B	4.22B	4.25B	3.08B	1.53B	1.05B
Net Income	3.88B	2.41B	2.64B	2.68B	3.25B	3.3B	2.42B	1.15B	809.07M
Selling & General & Admin	11.09B	10.16B	7.85B	6.29B	5.98B	4.93B	2.51B	2.1B	1.78B
Research & Development	3.54B	2.8B	2.35B	1.99B	1.59B	1.5B	1.09B	907.72M	777.59M
Other Expenses	-6M	105M	-32M	-30M	-2M	-16M	n/a	471K	1.7M
Operating Expenses	14.62B	13.06B	10.17B	8.26B	7.57B	6.41B	3.6B	3.01B	2.55B
Interest Expense	n/a	1.11B	458M	n/a	454M	241M	56.46M	63.97M	78.55M
Selling & Marketing Expenses	3.53B	n/a	n/a	n/a	n/a	4.93B	2.51B	2.1B	1.78B
Cost & Expenses	20.4B	18.06B	14.95B	11.74B	10.8B	9.75B	6.01B	4.86B	4.11B
Income Tax Expense	528M	546M	683M	616M	972M	942M	663.94M	383.81M	238.91M
Shares Outstanding (Basic)	341.73M	325.98M	309.48M	308.9M	308.49M	306.38M	270.6M	269.02M	268.36M
Shares Outstanding (Diluted)	345.56M	325.97M	312.46M	310.73M	311.61M	308.35M	270.6M	270M	269.22M
EPS (Basic)	11.37	7.39	8.52	8.67	10.52	10.78	8.93	4.27	3.01
EPS (Diluted)	11.24	7.39	8.44	8.62	10.41	10.72	8.93	4.25	3.01
EBITDA	9.3B	7.23B	6.05B	5.72B	6.69B	6.08B	3.62B	2.08B	1.57B
EBIT	5.63B	4.07B	3.78B	3.71B	4.67B	4.49B	3.14B	1.6B	1.13B
Depreciation & Amortization	3.68B	3.17B	2.27B	2B	2.02B	1.51B	484.57M	473.98M	440.71M